In 2013, the Society for Maternal-Fetal Medicine (SMFM)
Publications Committee adopted the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system for evaluating and rating scientific
evidence and practice recommendations for SMFM
Clinical Guidelines and Consults.1 This decision...
A clinical summary of this KDP was published in the Journal of the Ministry of Health of the Czech Republic .
Ischemic cerebrovascular events (iCMP) make up 88% of all CMPs, in the Czech Republic the incidence of iCMP is currently 211 cases per 100,000 inhabitants per year and the prevalence is estimat...
This guideline covers diagnosing and managing venous thromboembolic diseases in adults. It aims to support rapid diagnosis and effective treatment for people who develop deep vein thrombosis (DVT) or pulmonary embolism (PE). It also covers testing for conditions that can make a DVT or PE more likely, suc...
Generar recomendaciones basadas en la mejor evidencia disponible acerca del manejo clínico de las
personas de 15 años y más con Ataque Cerebrovascular isquémico....
This guideline covers the assessment and early management of head injury in children, young people and adults. It promotes effective clinical assessment so that people receive the right care for the severity of their head injury, including referral directly to specialist care if needed. In September 2019...
Atrial fibrillation (AF) is the most common cardiac arrhythmia with a worldwide prevalence of approximately 2% (3, 4, 5). The occurrence of the disease depends on age, the prevalence among people under 60 years old is less than 1%, among people 80 years old and older it is 7...9%. Based on prevalence ind...
Romano, C;
van, Wynckel, M;
Hulst, J;
Broekaert, I;
Bronsky, J;
Dall'Oglio, L;
Mis, NF;
Hojsak, I;
Orel, R;
Papadopoulou, A;
Schaeppi, M;
Thapar, N;
Wilschanski, M;
Sullivan, P;
Gottrand, F.
BACKGROUND AND PURPOSE: Current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological Societies in 2010. We aimed to update the previous European Federation of Neurological Societies guidelines using a clearer and evidence-based met...
Berríos-Torres, S. I;
Umscheid, C. A;
Bratzler, D. W;
Leas, B;
Stone, E. C;
Kelz, R. R;
Reinke, C. E;
Morgan, S;
Solomkin, J. S;
Mazuski, J. E;
Dellinger, E. P;
Itani, K. M. F;
Berbari, E. F;
Segreti, J;
Parvizi, J;
Blanchard, J;
Allen, G;
Kluytmans, J. A. J. W;
Donlan, R;
Schecter, W. P.
IMPORTANCE: The human and financial costs of treating surgical site infections (SSIs) are increasing. The number of surgical procedures performed in the United States continues to rise, and surgical patients are initially seen with increasingly complex comorbidities. It is estimated that approximately ha...
Macle, L;
Cairns, J;
Leblanc, K;
Tsang, T;
Skanes, A;
Cox, JL;
Healey, JS;
Bell, A;
Pilote, L;
Andrade, JG;
Mitchell, LB;
Atzema, C;
Gladstone, D;
Sharma, M;
Verma, S;
Connolly, S;
Dorian, P;
Parkash, R;
Talajic, M;
Nattel, S;
Verma, A.
The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
Anticoagulants,
Cardiotonic Agents,
Platelet Aggregation Inhibitors,
Digoxin,
Magnesium,
Acute Coronary Syndrome/therapy,
Algorithms,
Anticoagulants/therapeutic use,
Atrial Appendage/surgery,
Atrial Fibrillation,
Cardiac Pacing, Artificial,
Cardiotonic Agents/adverse effects,
Catheter Ablation,
Cardiotonic Agents/administration & dosage,
Atrial Fibrillation/therapy,
Atrial Fibrillation/complications,
Hemorrhage/chemically induced,
Hemorrhage/prevention & control,
Magnesium/therapeutic use,
Percutaneous Coronary Intervention,
Platelet Aggregation Inhibitors/therapeutic use,
Postoperative Complications/prevention & control,
ST Elevation Myocardial Infarction/therapy,
Stroke/prevention & control,
Coronary Artery Disease/complications,
Digoxin/administration & dosage,
Digoxin/adverse effects,
Drug Therapy, Combination,
Factor Xa Inhibitors/therapeutic use,
Fibrinolytic Agents/therapeutic use,
Factor Xa Inhibitors
Al-Hameed, F. M;
Al-Dorzi, H. M;
Abdelaal, M. A;
Alaklabi, A;
Bakhsh, E;
Alomi, Y. A;
Al Baik, M;
Aldahan, S;
Schünemann, H;
Brozek, J;
Wiercioch, W;
Darzi, A. J;
Waziry, R;
Akl, E. A.
Venous thromboembolism (VTE) acquired during hospitalization is common, yet preventable by the proper implementation of thromboprophylaxis which remains to be underutilized worldwide. As a result of an initiative by the Saudi Ministry of Health to improve medical practices in the country, an expert panel...
